HOME | ARTICLES | EDITORIALS | SUPPLEMENTS |CASE REPORTS

Stay up-to-date on new clinical findings in Hair and Scalp.

Alopecia can be categorized as cicatricial and non-cicatricial, with female androgenetic alopecia (AGA) and female pattern hair loss (FPHL) included in the latter category.

Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil are scarce. Over the past several years, new combinations of natural ingredients and patented mixtures have shown promising results to improve hair shedding, thus helping recover self-esteem and confidence. In this work, results of a prospective, open-label clinical trial conducted in women of predominantly menopausal age provides evidence that the dual cosmetic serum system developed by KilgourMD displays statistically significant and clinically meaningful effects on female hair loss, measured through an objective combing test, modified hair wash test, and clinical expert evaluation, after an application period of 4 months.

Alopecia Areata: The Clinician and Patient Voice

The review synthesizes clinician and patient survey data to describe the lived burden of alopecia areata, the condition course, and current care gaps. It highlights the profound psychosocial impact and quality of life impairments that patients experience, including anxiety and depression, and summarizes clinician observations about diagnostic challenges and therapeutic limitations.

Article Highlight: Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia

This article from November’s JDD study reveals a potential game-changer in the fight against Androgenetic Alopecia (male pattern baldness). Researchers compared two popular treatments for hair regrowth, and one combination therapy delivered significantly superior results. Could this new approach offer a more effective solution for millions of men?

AI-Powered Personalization for Hair Loss: A Promising Alternative?

With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results. Could AI-driven customization be the answer?

Beyond Minoxidil: Is It Time to Rethink Female Hair Loss Treatment?

More than half of postmenopausal women, and a significant percentage of younger, healthy women, struggle with visible hair loss, often starting as early as their reproductive years. Whether it’s androgenetic alopecia, telogen effluvium, or scarring forms like lichen planopilaris and central centrifugal cicatricial alopecia, the psychological toll is undeniable. Yet, despite its prevalence, FDA-approved treatment options remain frustratingly limited.

Emerging Topical Approaches in the Management of Female Pattern Hair Loss

Alopecia can be categorized as cicatricial and non-cicatricial, with female androgenetic alopecia (AGA) and female pattern hair loss (FPHL) included in the latter category.

Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss

Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil are scarce. Over the past several years, new combinations of natural ingredients and patented mixtures have shown promising results to improve hair shedding, thus helping recover self-esteem and confidence.